H. M. Patel

Dr. H. M. Patel

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HPH. M. Patel
H. M. Patel
RPRahul Pawara
Rahul Pawara
AAAzim Ansari
Azim Ansari
SSSanjay Surana
Sanjay Surana

22 February 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Rameshwar ChekeRameshwar Cheke
Rameshwar Cheke
VPVaishali Patil
Vaishali Patil
SFSandip D. Firke
Sandip D. Firke
JAJAYA PRAKASH AMBHORE
JAYA PRAKASH AMBHORE
IQRAR AHMADIQRAR AHMAD
IQRAR AHMAD
Mejdi SnoussiMejdi Snoussi
Mejdi Snoussi
Isatin (1H indole 2, 3-dione) is a heterocyclic, endogenous lead molecule recognized in humans and different plants. The isatin nucleus and its derivatives are owed the attention of researchers due to their diverse pharmacological activities such as anticancer, anti-TB, antifungal, antimicrobial, antioxidant, anti-inflammatory, anticonvulsant, anti-HIV, and so on. Many research chemists take advantage of the gentle structure of isatins, such as NH at position 1 and carbonyl functions at positions 2 and 3, for designing biologically active analogues via different approaches. Literature surveys based on reported preclinical, clinical, and patented details confirm the multitarget profile of isatin analogues and thus their importance in the field of medicinal chemistry as a potent chemotherapeutic agent. This review represents the recent development of isatin analogues possessing potential pharmacological action in the years 2016–2020. The structure–activity relationship is also discussed to provide a pharmacophoric pattern that may contribute in the future to the design and synthesis of potent and less toxic therapeutics.

Verified
Journal Article
Open access
PDF file
RZRafat Zrieq
Rafat Zrieq
IQRAR AHMADIQRAR AHMAD
IQRAR AHMAD
Mejdi SnoussiMejdi Snoussi
Mejdi Snoussi
Emira NoumiEmira Noumi
Emira Noumi
Marcello IritiMarcello Iriti
Marcello Iriti
AKAdel Kadri
Adel Kadri
Considering the current dramatic and fatal situation due to the high spreading of SARS-CoV-2 infection, there is an urgent unmet medical need to identify novel and effective approaches for prevention and treatment of Coronavirus disease (COVID 19) by re-evaluating and repurposing of known drugs. For this, tomatidine and patchouli alcohol have been selected as potential drugs for combating the virus. The hit compounds were subsequently docked into the active site and molecular docking analyses revealed that both drugs can bind the active site of SARS-CoV-2 3CLpro, PLpro, NSP15, COX-2 and PLA2 targets with a number of important binding interactions. To further validate the interactions of promising compound tomatidine, Molecular dynamics study of 100 ns was carried out towards 3CLpro, NSP15 and COX-2. This indicated that the protein-ligand complex was stable throughout the simulation period, and minimal backbone fluctuations have ensued in the system. Post dynamic MM-GBSA analysis of molecular dynamics data showed promising mean binding free energy 47.4633 ± 9.28, 51.8064 ± 8.91 and 54.8918 ± 7.55 kcal/mol, respectively. Likewise, in silico ADMET studies of the selected ligands showed excellent pharmacokinetic properties with good absorption, bioavailability and devoid of toxicity. Therefore, patchouli alcohol and especially, tomatidine may provide prospect treatment options against SARS-CoV-2 infection by potentially inhibiting virus duplication though more research is guaranteed and secured.

24 April 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
Rameshwar ChekeRameshwar Cheke
Rameshwar Cheke
HPH. M. Patel
H. M. Patel
VPVaishali Patil
Vaishali Patil
IQRAR AHMADIQRAR AHMAD
IQRAR AHMAD
JAJAYA PRAKASH AMBHORE
JAYA PRAKASH AMBHORE
PDPrashant Deshmukh
Prashant Deshmukh
A major global health risk has been witnessed with the development of drug-resistant bacteria and multidrug-resistant pathogens linked to significant mortality. Coumarins are heterocyclic compounds belonging to the benzophenone class enriched in different plants. Coumarins and their derivatives have a wide range of biological activity, including antibacterial, anticoagulant, antioxidant, anti-inflammatory, antiviral, antitumour, and enzyme inhibitory effects. In the past few years, attempts have been reported towards the optimization, synthesis, and evaluation of novel coumarin analogues as antimicrobial agents. Several coumarin-based antibiotic hybrids have been developed, and the majority of them were reported to exhibit potential antibacterial effects. In the present work, studies reported from 2016 to 2020 about antimicrobial coumarin analogues are the focus. The diverse biological spectrum of coumarins can be attributed to their free radical scavenging abilities. In addition to various synthetic strategies developed, some of the structural features include a heterocyclic ring with electron-withdrawing/donating groups conjugated with the coumarin nucleus. The suggested structure−activity relationship (SAR) can provide insight into how coumarin hybrids can be rationally improved against multidrug-resistant bacteria. The present work demonstrates molecular insights for coumarin derivatives having antimicrobial properties from the recent past. The detailed SAR outcomes will benefit towards leading optimization during the discovery and development of novel antimicrobial therapeutics.

29 July 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MSMatin Shaikh
Matin Shaikh
YSYashodeep Shinde
Yashodeep Shinde
RPRahul Pawara
Rahul Pawara
MNMalleshappa Noolvi
Malleshappa Noolvi
SSSanjay Surana
Sanjay Surana
HPH. M. Patel
H. M. Patel

1 November 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KCKavita Chaudhari
Kavita Chaudhari
SSSanjay Surana
Sanjay Surana
PJPritam Jain
Pritam Jain
HPH. M. Patel
H. M. Patel